ANA 2021: Efgartigimod Proves Effective for Generalized Myasthenia Gravis
No significant safety issues were reported.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No significant safety issues were reported.
Only registered members have full access to PracticeUpdate content.